Insulet Total Long-Term Assets 2010-2024 | PODD

Insulet total long-term assets for the quarter ending September 30, 2024 were $1.165B, a 16.85% increase year-over-year.

  • Insulet total long-term assets for 2023 were $1.005B, a 7.28% increase from 2022.
  • Insulet total long-term assets for 2022 were $0.937B, a 30.33% increase from 2021.
  • Insulet total long-term assets for 2021 were $0.719B, a 15.19% increase from 2020.

Insulet Total Long-Term Assets 2010-2024 | PODD

  • Insulet total long-term assets for 2023 were $1.005B, a 7.28% increase from 2022.
  • Insulet total long-term assets for 2022 were $0.937B, a 30.33% increase from 2021.
  • Insulet total long-term assets for 2021 were $0.719B, a 15.19% increase from 2020.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$203.4B
Stryker (SYK)$148.7B
Boston Scientific (BSX)$134.9B
EssilorLuxottica (ESLOY)$111.5B
Medtronic (MDT)$108.7B
Haleon (HLN)$43.2B
Lonza Group Ag (LZAGY)$42.4B
GE HealthCare Technologies (GEHC)$37.5B
ResMed (RMD)$35.8B
Terumo (TRUMY)$29.4B
Koninklijke Philips (PHG)$24.8B
Zimmer Biomet Holdings (ZBH)$21.6B
Baxter (BAX)$16.8B
Smith & Nephew SNATS (SNN)$10.9B
BellRing Brands (BRBR)$9.9B
Bio-Rad Laboratories (BIO)$9.1B
Demant (WILYY)$8.3B
Lantheus Holdings (LNTH)$6.1B
TG Therapeutics (TGTX)$5.4B
Haemonetics (HAE)$4.3B
Prestige Consumer Healthcare (PBH)$4.2B
ICU Medical (ICUI)$4.1B
Perrigo (PRGO)$3.7B
Envista Holdings (NVST)$3.7B
Agios Pharmaceuticals (AGIO)$3.2B
Neogen (NEOG)$3.2B
Shandong Weigao Medical Polymer (SHWGF)$3B
GN Store Nord (GNNDY)$2.8B
QuidelOrtho (QDEL)$2.5B
LeMaitre Vascular (LMAT)$2.4B